Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Next-generation stem cells cleared for human trial

Nature (2014)Cite this article

Subjects

This article has been updated

Japanese team will use 'iPS' cells to treat patient with degenerative eye disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Change history

  • 12 September 2014

    The article has been updated to report the news that the anticipated procedure took place on 12 September.

References

  1. Kamao, H. et al. Stem Cell Rep. 2, 205–218 (2014).

    Article  ADS  CAS  Google Scholar 

  2. Kanemura, H. et al. PLoS ONE 9, e85336 (2014).

    Article  ADS  Google Scholar 

Download references

Authors
  1. David Cyranoski
    View author publications

    Search author on:PubMed Google Scholar

Related links

Related links

Related links in Nature Research

Stem cells cruise to clinic 2013-Feb-27

Cell rewind wins medicine Nobel 2012-Oct-08

Nature Special: The rise and fall of STAP

Nature Special: Stem cell injunction

Nature Focus: iPS cells

Related external links

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cyranoski, D. Next-generation stem cells cleared for human trial. Nature (2014). https://doi.org/10.1038/nature.2014.15897

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/nature.2014.15897

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research